Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis

Long-term effects of SGLT2 inhibitors on arrhythmias: a systematic review and meta-analysis

AimsSodium-glucose co-transporter 2 (SGLT2) inhibitors are novel oral hypoglycemic agents strongly endorsed in the treatment guidelines for heart failure due to their cardioprotective benefits. However, their specific impact of SGLT2 inhibitors on arrhythmias incompletely understood. This systematic...

Full description

Saved in:

Bibliographic Details
Main Authors:	Peipei Li, Weiwei Chen, Rui Chen, Hanmo Zhang, Zhixi Yu, Hongyu Yan, Beibei Du, Ping Yang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pharmacology
Subjects:	sodium-glucose co-transporter 2 inhibitors arrhythmia atrial fibrillation atrial flutter meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1558367/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The preventive effect of sodium-glucose co-transporter-2 inhibitors on atrial fibrillation and atrial flutter in patients with chronic kidney disease: a meta-analysis
by: Qian Yang, et al.
Published: (2025-05-01)

Epidemiology and Clinical Outcomes of Cardiac Arrhythmias in Pulmonary Arterial HypertensionTake-Home Points
by: Thanaboon Yinadsawaphan, MD, et al.
Published: (2025-03-01)

Atrial fibrillation or flutter in patients undergoing stem cell transplantation, in-hospital and post-discharge outcomes in a large nationwide sample across the United States
by: Raja Zaghlol, et al.
Published: (2025-07-01)

Neonatal atrial flutter: Three cases and review of the literature
by: Seda Yılmaz-Semerci, et al.
Published: (2018-06-01)

Relief of persistent atypical atrial flutter: experience with the use of niferidil
by: E. A. Zakharyan, et al.
Published: (2023-03-01)

Clinical study of Russian class III antiarrhythmic agent, nibentan, in supraventricular arrhythmia management
by: V. G. Valiev, et al.
Published: (2005-12-01)

COMPARISON RESULTS OF THE INTRACARDIAC ELECTROPHYSIOLOGICAL STUDY IN PATIENTS WITH TYPICAL ATRIAL FLUTTER AND FIBRILLATION
by: P. S. Novikov, et al.
Published: (2017-08-01)

Temporal trends of catheter ablation procedures in patients with atrial fibrillation and atrial flutter: A nationwide cohort study
by: Antti Lappalainen, et al.
Published: (2024-12-01)

Asymptomatic Supraventricular Arrhythmias in Patients Undergoing Dialysis
by: O. V. Likhachev-Mishchenko, et al.
Published: (2021-03-01)

Arrhythmias in COVID-19
by: Summit Pandat, et al.
Published: (2021-12-01)

Outcomes in patients with cardiac amyloidosis undergoing catheter ablation for atrial arrhythmias
by: Adrian M. Petzl, MD, et al.
Published: (2025-08-01)

Characterizing the recurrence of atrial arrhythmia following macro-reentrant atrial tachycardia ablation in adult patients with repaired tetralogy of Fallot
by: Bret L. Pinsker, MD, et al.
Published: (2025-08-01)

Recent Advances in Understanding the Molecular Mechanisms of SGLT2 Inhibitors in Atrial Remodeling
by: Ioan-Alexandru Minciună, et al.
Published: (2024-08-01)

Prevalence of cardiac arrhythmias among patients undergoing chronic hemodialysis
by: O. V. Likhachev-Mishchenko, et al.
Published: (2022-12-01)

Guidelines for Holter and Wearable Electrocardiogram Monitoring in Arrhythmia Diagnosis and the Role of Medical Technologists
by: Do-Hee KIM, et al.
Published: (2025-06-01)

The Risk of Arrhythmias in Patients with COVID-19
by: Lina Haj Ali, et al.
Published: (2025-06-01)

Trends in atrial fibrillation and flutter mortality associated with disorders of thyroid gland in the United States from 1999 to 2020
by: Shahzaib Ahmed, et al.
Published: (2025-06-01)

Comparison of traditional radiofrequency ablation and high-power short-duration ablation in the treatment of atrial tachyarrhythmias
by: A. V. Yakushev, et al.
Published: (2022-09-01)

Comparative characteristics of different methods of radiofrequency catheter ablation in atrial flutter
by: A. V. Yakushev, et al.
Published: (2022-11-01)

EHRA classes, additional cardiovascular risk and quality of life in patients during the first six months of atrial flutter and atrial fibrillation radiofrequency
by: M. S. Brynza, et al.
Published: (2018-06-01)

THE PREVALENCE AND CLINICAL SIGNIFICANCE OF CARDIAC ARRHYTHMIAS
by: E. V. Zatonskaya, et al.
Published: (2017-07-01)

Association of atrial fibrillation and atrial flutter with sick sinus syndrome: a review of the issue based on examples of clinical observations
by: O. Yu. Schmidt, et al.
Published: (2022-05-01)

Trends in United States mortality among patients with atrial fibrillation/flutter related heart failure (1999–2024): disparities by gender, race/ethnicity and region
by: Suraksha Rani, et al.
Published: (2025-07-01)

Differentiated approach to rhythm conversion in patients with atrial fibrillation and flutter
by: A. G. Pronin, et al.
Published: (2021-12-01)

Sex-specific trends in the global burden and risk factors of atrial fibrillation and flutter from 1990 to 2021
by: Xiaodong Peng, et al.
Published: (2025-03-01)

Association of calcium supplement with risk of incident arrhythmia
by: Ru Chen, et al.
Published: (2025-07-01)

Concurrent validity testing of the patient perspective of arrhythmia questionnaire
by: Kathryn A. Wood, et al.
Published: (2025-06-01)

Atrial Flutter in Acute Inferior Wall Myocardial Infarction Successfully Treated with Reperfusion Therapy
by: Gautam Jesrani, et al.
Published: (2025-01-01)

ROLE OF HYPERTENSION AND SUPRAVENTRICULAR ARRHYTHMIAS IN COGNITIVE IMPAIRMENTS: THE CURRENT PROBLEM STATE
by: N. N. Kriukov, et al.
Published: (2015-09-01)

Neuromodulation of the Cardiac Autonomic Nervous System for Arrhythmia Treatment
by: Benjamin Wong, et al.
Published: (2025-07-01)

Anticoagulant therapy in catheter ablation of atrial fibrillation and flutter
by: M. V. Serova, et al.
Published: (2021-09-01)

Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation
by: M. A. Zelberg, et al.
Published: (2024-05-01)

Global burden and health inequality of atrial fibrillation/atrial flutter from 1990 to 2021
by: Xia Li, et al.
Published: (2025-05-01)

Global trends and regional disparities in atrial fibrillation and flutter burden attributable to high alcohol consumption: findings from the global burden of disease study 2021
by: Yunkai Hua, et al.
Published: (2025-04-01)

Global trends and epidemiological impact of metabolic risk factors on atrial fibrillation and atrial flutter from 1990 to 2021
by: Junqing Liang, et al.
Published: (2025-02-01)

Stroke prophylaxis after US emergency department diagnosis and discharge of patients with atrial fibrillation and flutter from 21 hospitals
by: Bory Kea, et al.
Published: (2025-05-01)

Secular trend in disease burden of atrial fibrillation/flutter in China from 1992 to 2021 and its projection in 25 years
by: Chuanmeng Zhang, et al.
Published: (2025-06-01)

Arrhythmias Following Patent Foramen Ovale Closure: An Unsolved Enigma
by: Aikaterini-Eleftheria Karanikola, et al.
Published: (2024-12-01)

Intracardiac Echocardiography and Ablation of Atrial Fibrillation in Dextrocardia
by: Shuang Zhang, et al.
Published: (2024-11-01)

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
by: A. O. Malygin, et al.
Published: (2015-09-01)